Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

Publisher： Karger

E-ISSN： 1424-8840|30|2|136-140

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.30, Iss.2, 2004-11, pp. : 136-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unfractionated Heparin and Low-Molecular-Weight Heparin for the Initial Treatment of Acute Venous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 85-90

Karger

Access to resources Recommend Favorite

Secondary Prevention of Venous Thromboembolism: A Role for Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 5, 1999-07 ,pp. : 236-243

Karger

Access to resources Recommend Favorite

Home Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 83-84

Karger

Access to resources Recommend Favorite

Effect of Patient Weight on the Anticoagulant Response to Adjusted Therapeutic Dosage of Low-Molecular- Weight Heparin for the Treatment ofVenous Thromboembolism

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 1, 2001-06 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin versus Unfractionated Heparin in the Treatment of Patients with Acute Pulmonary Thromboembolism

By  

Respiration, Vol. 69, Iss. 5, 2002-09 ,pp. : 440-444

Karger

Access to resources Recommend Favorite